Eurofins-Cerep SA - Asset Resilience Ratio

Latest as of December 2025: 13.39%

Eurofins-Cerep SA (ALECR) has an Asset Resilience Ratio of 13.39% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€11.92 Million

≈ $13.93 Million USD Cash + Short-term Investments

Total Assets

€89.02 Million

≈ $104.07 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how Eurofins-Cerep SA's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Eurofins-Cerep SA to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Eurofins-Cerep SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Eurofins-Cerep SA.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€11.92 Million	13.39%
Total Liquid Assets	€11.92 Million	13.39%

Asset Resilience Insights

Moderate Liquidity: Eurofins-Cerep SA has 13.39% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Eurofins-Cerep SA Industry Peers by Asset Resilience Ratio

Compare Eurofins-Cerep SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Chemclin Diagnostics Co. Ltd. A SHG:688468	Diagnostics & Research	15.34%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Check Cap Ltd NASDAQ:CHEK	Diagnostics & Research	70.29%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Cryosite Ltd AU:CTE	Diagnostics & Research	5.65%

Annual Asset Resilience Ratio for Eurofins-Cerep SA (2000–2025)

The table below shows the annual Asset Resilience Ratio data for Eurofins-Cerep SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	13.39%	€11.92 Million ≈ $13.93 Million	€89.02 Million ≈ $104.07 Million	+14.06pp
2018-12-31	-0.67%	€-237.72K ≈ $-277.92K	€35.26 Million ≈ $41.22 Million	+28.92pp
2017-12-31	-29.59%	€-8.93 Million ≈ $-10.44 Million	€30.18 Million ≈ $35.28 Million	-22.22pp
2016-12-31	-7.37%	€-1.91 Million ≈ $-2.23 Million	€25.94 Million ≈ $30.33 Million	+15.31pp
2015-12-31	-22.67%	€-5.71 Million ≈ $-6.68 Million	€25.18 Million ≈ $29.44 Million	-24.86pp
2014-12-31	2.18%	€500.00K ≈ $584.55K	€22.90 Million ≈ $26.77 Million	-9.40pp
2013-12-31	11.59%	€3.23 Million ≈ $3.78 Million	€27.89 Million ≈ $32.60 Million	-11.39pp
2012-12-31	22.97%	€6.96 Million ≈ $8.13 Million	€30.28 Million ≈ $35.40 Million	-4.19pp
2011-12-31	27.17%	€8.89 Million ≈ $10.39 Million	€32.72 Million ≈ $38.26 Million	+3.61pp
2010-12-31	23.56%	€8.46 Million ≈ $9.89 Million	€35.90 Million ≈ $41.97 Million	-12.21pp
2009-12-31	35.77%	€15.85 Million ≈ $18.53 Million	€44.31 Million ≈ $51.80 Million	+0.59pp
2008-12-31	35.19%	€19.32 Million ≈ $22.59 Million	€54.91 Million ≈ $64.19 Million	+3.14pp
2007-12-31	32.04%	€20.10 Million ≈ $23.50 Million	€62.73 Million ≈ $73.34 Million	+31.62pp
2006-12-31	0.42%	€321.00K ≈ $375.28K	€76.37 Million ≈ $89.29 Million	-9.48pp
2005-12-31	9.90%	€8.29 Million ≈ $9.69 Million	€83.65 Million ≈ $97.79 Million	-7.68pp
2004-12-31	17.59%	€11.23 Million ≈ $13.13 Million	€63.87 Million ≈ $74.68 Million	-20.56pp
2003-12-31	38.14%	€19.55 Million ≈ $22.85 Million	€51.24 Million ≈ $59.91 Million	+1.01pp
2002-12-31	37.14%	€17.72 Million ≈ $20.72 Million	€47.72 Million ≈ $55.78 Million	-2.14pp
2001-12-31	39.27%	€16.06 Million ≈ $18.78 Million	€40.90 Million ≈ $47.81 Million	+13.61pp
2000-12-31	25.66%	€6.07 Million ≈ $7.10 Million	€23.67 Million ≈ $27.67 Million	--

pp = percentage points

About Eurofins-Cerep SA

PA:ALECR France Diagnostics & Research

Market Cap

$96.12 Million

€82.22 Million EUR

Market Cap Rank

#19665 Global

#299 in France

Share Price

€16300.00

Change (1 day)

+0.00%

52-Week Range

€15300.00 - €18600.00

All Time High

€18600.00